Kaitlyn Arsenault - Oct 4, 2021 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Chief Financial Officer
Signature
Kaitlyn Arsenault
Stock symbol
SKYE
Transactions as of
Oct 4, 2021
Transactions value $
$0
Form type
3
Date filed
10/5/2021, 08:40 PM
Next filing
Dec 16, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SKYE Stock Option (Right to Buy) Oct 4, 2021 Common Stock 400K $0.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 10% of the Options shall vest on September 15, 2021 (the "Vesting Start Date") and the remaining 90% will vest in equal annual installments on the anniversary of the Vesting Start Date over four annual periods.